Click here to close
Hello! We notice that you are using Internet Explorer, which is not supported by Xenbase and may cause the site to display incorrectly.
We suggest using a current version of Chrome,
FireFox, or Safari.
J Biol Chem
2010 May 28;28522:16504-12. doi: 10.1074/jbc.M109.072140.
Show Gene links
Show Anatomy links
Inhibition of Na+-taurocholate Co-transporting polypeptide-mediated bile acid transport by cholestatic sulfated progesterone metabolites.
Abu-Hayyeh S
,
Martinez-Becerra P
,
Sheikh Abdul Kadir SH
,
Selden C
,
Romero MR
,
Rees M
,
Marschall HU
,
Marin JJ
,
Williamson C
.
???displayArticle.abstract???
Sulfated progesterone metabolite (P4-S) levels are raised in normal pregnancy and elevated further in intrahepatic cholestasis of pregnancy (ICP), a bile acid-liver disorder of pregnancy. ICP can be complicated by preterm labor and intrauterine death. The impact of P4-S on bile acid uptake was studied using two experimental models of hepatic uptake of bile acids, namely cultured primary human hepatocytes (PHH) and Na(+)-taurocholate co-transporting polypeptide (NTCP)-expressing Xenopus laevis oocytes. Two P4-S compounds, allopregnanolone-sulfate (PM4-S) and epiallopregnanolone-sulfate (PM5-S), reduced [(3)H]taurocholate (TC) uptake in a dose-dependent manner in PHH, with both Na(+)-dependent and -independent bile acid uptake systems significantly inhibited. PM5-S-mediated inhibition of TC uptake could be reversed by increasing the TC concentration against a fixed PM5-S dose indicating competitive inhibition. Experiments using NTCP-expressing Xenopus oocytes confirmed that PM4-S/PM5-S are capable of competitively inhibiting NTCP-mediated uptake of [(3)H]TC. Total serum PM4-S + PM5-S levels were measured in non-pregnant and third trimester pregnant women using liquid chromatography-electrospray tandem mass spectrometry and were increased in pregnant women, at levels capable of inhibiting TC uptake. In conclusion, pregnancy levels of P4-S can inhibit Na(+)-dependent and -independent influx of taurocholate in PHH and cause competitive inhibition of NTCP-mediated uptake of taurocholate in Xenopus oocytes.
Arrese,
Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat.
2003, Pubmed
Arrese,
Down-regulation of the Na+/taurocholate cotransporting polypeptide during pregnancy in the rat.
2003,
Pubmed
Bacq,
Intrahepatic cholestasis of pregnancy: a French prospective study.
1997,
Pubmed
Briz,
Carriers involved in targeting the cytostatic bile acid-cisplatin derivatives cis-diammine-chloro-cholylglycinate-platinum(II) and cis-diammine-bisursodeoxycholate-platinum(II) toward liver cells.
2002,
Pubmed
,
Xenbase
Castaño,
Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy.
2006,
Pubmed
Crocenzi,
Estradiol-17beta-D-glucuronide induces endocytic internalization of Bsep in rats.
2003,
Pubmed
Diac,
Dexamethasone in the treatment of obstetric cholestasis: a case series.
2006,
Pubmed
Dixon,
Heterozygous MDR3 missense mutation associated with intrahepatic cholestasis of pregnancy: evidence for a defect in protein trafficking.
2000,
Pubmed
Dixon,
Contribution of variant alleles of ABCB11 to susceptibility to intrahepatic cholestasis of pregnancy.
2009,
Pubmed
Dixon,
The molecular genetics of intrahepatic cholestasis of pregnancy.
2008,
Pubmed
Eloranta,
The human Na+-taurocholate cotransporting polypeptide gene is activated by glucocorticoid receptor and peroxisome proliferator-activated receptor-gamma coactivator-1alpha, and suppressed by bile acids via a small heterodimer partner-dependent mechanism.
2006,
Pubmed
Ganguly,
Prolactin increases Na+/taurocholate cotransport in isolated hepatocytes from postpartum rats and ovariectomized rats.
1993,
Pubmed
Geier,
Regulation of basolateral organic anion transporters in ethinylestradiol-induced cholestasis in the rat.
2003,
Pubmed
Glantz,
Intrahepatic cholestasis of pregnancy: a randomized controlled trial comparing dexamethasone and ursodeoxycholic acid.
2005,
Pubmed
Glantz,
Intrahepatic cholestasis of pregnancy: Amelioration of pruritus by UDCA is associated with decreased progesterone disulphates in urine.
2008,
Pubmed
Glantz,
Intrahepatic cholestasis of pregnancy: Relationships between bile acid levels and fetal complication rates.
2004,
Pubmed
Hirvioja,
The treatment of intrahepatic cholestasis of pregnancy by dexamethasone.
1992,
Pubmed
Ho,
Ethnicity-dependent polymorphism in Na+-taurocholate cotransporting polypeptide (SLC10A1) reveals a domain critical for bile acid substrate recognition.
2004,
Pubmed
Kancheva,
Relationships of circulating pregnanolone isomers and their polar conjugates to the status of sex, menstrual cycle, and pregnancy.
2007,
Pubmed
Kim,
Modulation by drugs of human hepatic sodium-dependent bile acid transporter (sodium taurocholate cotransporting polypeptide) activity.
1999,
Pubmed
Kullak-Ublick,
Stable expression and functional characterization of a Na+-taurocholate cotransporting green fluorescent protein in human hepatoblastoma HepG2 cells.
2000,
Pubmed
Marschall,
Isoursodeoxycholic acid: metabolism and therapeutic effects in primary biliary cirrhosis.
2001,
Pubmed
Meier,
Increased susceptibility for intrahepatic cholestasis of pregnancy and contraceptive-induced cholestasis in carriers of the 1331T>C polymorphism in the bile salt export pump.
2008,
Pubmed
Meng,
Profiles of bile acids and progesterone metabolites in the urine and serum of women with intrahepatic cholestasis of pregnancy.
1997,
Pubmed
Müllenbach,
ABCB4 gene sequence variation in women with intrahepatic cholestasis of pregnancy.
2003,
Pubmed
Müllenbach,
ATP8B1 mutations in British cases with intrahepatic cholestasis of pregnancy.
2005,
Pubmed
Pascual,
Relationship between asymptomatic hypercholanaemia of pregnancy and progesterone metabolism.
2002,
Pubmed
Pauli-Magnus,
Sequence analysis of bile salt export pump (ABCB11) and multidrug resistance p-glycoprotein 3 (ABCB4, MDR3) in patients with intrahepatic cholestasis of pregnancy.
2004,
Pubmed
Sandker,
Characterization of transport in isolated human hepatocytes. A study with the bile acid taurocholic acid, the uncharged ouabain and the organic cations vecuronium and rocuronium.
1994,
Pubmed
Selden,
Growth factors improve gene expression after lentiviral transduction in human adult and fetal hepatocytes.
2007,
Pubmed
Sjövall,
Steroid sulphates in plasma from pregnant women with pruritus and elevated plasma bile acid levels.
1970,
Pubmed
Sjövall,
Gas chromatographic determination of steroid sulphates in plasma during pregnancy.
1970,
Pubmed
Tagliacozzi,
Quantitative analysis of bile acids in human plasma by liquid chromatography-electrospray tandem mass spectrometry: a simple and rapid one-step method.
2003,
Pubmed
Vallejo,
Potential role of trans-inhibition of the bile salt export pump by progesterone metabolites in the etiopathogenesis of intrahepatic cholestasis of pregnancy.
2006,
Pubmed
,
Xenbase
Van Mil,
Functional variants of the central bile acid sensor FXR identified in intrahepatic cholestasis of pregnancy.
2007,
Pubmed
Vicens,
Novel cationic and neutral glycocholic acid and polyamine conjugates able to inhibit transporters involved in hepatic and intestinal bile acid uptake.
2007,
Pubmed
,
Xenbase
Wasmuth,
Intrahepatic cholestasis of pregnancy: the severe form is associated with common variants of the hepatobiliary phospholipid transporter ABCB4 gene.
2007,
Pubmed
Williamson,
Clinical outcome in a series of cases of obstetric cholestasis identified via a patient support group.
2004,
Pubmed
Yamamoto,
Estrogen receptor alpha mediates 17alpha-ethynylestradiol causing hepatotoxicity.
2006,
Pubmed
Zimmerli,
Multispecificity of Na+-dependent taurocholate uptake in basolateral (sinusoidal) rat liver plasma membrane vesicles.
1989,
Pubmed
